Cardinal Health Cash Flow from Operating Activities 2012-2026 | CAH
Cardinal Health annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Cardinal Health cash flow from operating activities for the quarter ending March 31, 2026 was $1.659B, a 181.05% decline year-over-year.
- Cardinal Health cash flow from operating activities for the twelve months ending March 31, 2026 was $5.899B, a 237.47% increase year-over-year.
- Cardinal Health annual cash flow from operating activities for 2025 was $2.397B, a 36.28% decline from 2024.
- Cardinal Health annual cash flow from operating activities for 2024 was $3.762B, a 32.28% increase from 2023.
- Cardinal Health annual cash flow from operating activities for 2023 was $2.844B, a 10.43% decline from 2022.
|
Cardinal Health Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2025 | $2,397 |
| 2024 | $3,762 |
| 2023 | $2,844 |
| 2022 | $3,175 |
| 2021 | $2,429 |
| 2020 | $1,960 |
| 2019 | $2,722 |
| 2018 | $2,768 |
| 2017 | $1,184 |
| 2016 | $2,971 |
| 2015 | $2,540 |
| 2014 | $2,524 |
| 2013 | $1,727 |
| 2012 | $1,176 |
| 2011 | $1,395 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $50.715B | $222.578B |
| Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.? | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |